HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 516 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2023. The put-call ratio across all filers is 1.68 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,905,256 | +14.9% | 42,400 | +2.2% | 0.06% | +19.6% |
| Q2 2023 | $4,268,275 | -8.2% | 41,500 | -2.6% | 0.05% | -16.4% |
| Q1 2023 | $4,649,364 | -17.6% | 42,600 | -14.1% | 0.06% | -14.1% |
| Q4 2022 | $5,644,480 | +119.2% | 49,600 | +19.2% | 0.06% | +100.0% |
| Q3 2022 | $2,575,000 | -26.3% | 41,600 | -5.0% | 0.03% | -28.9% |
| Q2 2022 | $3,493,000 | -11.9% | 43,800 | +16.2% | 0.04% | 0.0% |
| Q1 2022 | $3,966,000 | -15.4% | 37,700 | -13.3% | 0.04% | -4.3% |
| Q4 2021 | $4,688,000 | +4.1% | 43,500 | +5.8% | 0.05% | -7.8% |
| Q3 2021 | $4,502,000 | -51.3% | 41,100 | -58.7% | 0.05% | -13.6% |
| Q2 2021 | $9,242,000 | +113.6% | 99,500 | +111.7% | 0.06% | -3.3% |
| Q1 2021 | $4,326,000 | +50.5% | 47,000 | +19.6% | 0.06% | +41.9% |
| Q4 2020 | $2,875,000 | – | 39,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,462,634 | $175,978,000 | 7.18% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,221,585 | $114,954,000 | 6.73% |
| JW Asset Management, LLC | 270,775 | $7,373,000 | 6.49% |
| KOPP INVESTMENT ADVISORS LLC | 104,462 | $2,845,000 | 5.23% |
| 1492 Capital Management LLC | 171,621 | $4,673,000 | 4.56% |
| Avoro Capital Advisors LLC | 4,000,000 | $108,920,000 | 4.54% |
| Paulson & Co. | 8,170,700 | $222,488,000 | 4.46% |
| Rhenman & Partners Asset Management AB | 1,025,000 | $27,911,000 | 3.50% |
| Redwood Investments, LLC | 1,376,066 | $37,470,000 | 2.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 218,000 | $5,938,000 | 2.74% |